Tekla World Healthcare Fund establishes $150M at-the-market equity offering program

Tekla World Healthcare Fund (NYSE: THW) (the “Fund”) has entered into a distribution agreement (the “Distribution Agreement”), dated December 14, 2022, with Foreside Fund Services, LLC (“Foreside”), pursuant to which the Fund may offer and sell common shares of beneficial interest, par value $0.01 per share (“Common Shares”) having an aggregate initial offering price of up to $150,000,000, from time to time, through Foreside as agent for the Fund for the offer and sale of Common Shares, in transactions deemed to be “at the market” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Offering”).

Foreside has entered into a sub-placement agent agreement, dated December 14, 2022 (the “Sub-Placement Agent Agreement”), with UBS Securities LLC (“UBS”) relating to the Common Shares to be offered under the Distribution Agreement. Pursuant to the Distribution Agreement, the Fund will compensate Foreside with respect to sales of Common Shares at a commission rate of 1.00% of the gross proceeds of the sale of Common Shares. Out of this commission, under the Sub-Placement Agent Agreement, Foreside will compensate UBS at a rate of up to 0.80% of the gross sales proceeds of the sale of the Common Shares sold by UBS.